{"id":3160,"date":"2026-09-13T09:00:00","date_gmt":"2026-09-13T13:00:00","guid":{"rendered":"https:\/\/www.insilens.com\/?p=3160"},"modified":"2026-09-15T19:59:15","modified_gmt":"2026-09-15T23:59:15","slug":"single-atom-edits-redirect-a-dual-degrader-scaffold","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=3160","title":{"rendered":"Single-Atom Edits Redirect a Dual Degrader Scaffold"},"content":{"rendered":"

\"\"<\/p>\n

Company<\/strong><\/p>\n

Academic Molecular-Editing Consortium<\/p>\n

Event Type<\/strong><\/p>\n

Preclinical Research Findings (Non-Peer-Reviewed Preprint)<\/p>\n

Modality<\/strong><\/p>\n

Targeted Protein Degradation (PROTAC and Molecular Glue)<\/p>\n

Asset<\/strong><\/p>\n

424-ND (NSD2-Directed PROTAC) and 424-GD (GSPT1 Molecular Glue), Derived From Dual Degrader LLC0424<\/p>\n

Target<\/strong><\/p>\n

NSD2 and GSPT1 via CRBN-Dependent Ternary Complex<\/p>\n

Disease Area<\/strong><\/p>\n

Prostate Cancer (NSD2\/androgen-receptor signaling); Oncology broadly (GSPT1 degradation)<\/p>\n

Summary<\/h4>\n

A bioRxiv preprint reports that small \u201cmolecular editing\u201d changes converted LLC0424, a dual NSD2\/GSPT1 degrader, into two selective compounds: fluorine substitution produced the NSD2-directed PROTAC 424-ND, while methylene insertion produced the GSPT1 molecular glue 424-GD. The work links small scaffold changes to different CRBN ternary-complex conformations and degradation outcomes. It offers a potentially general medicinal-chemistry strategy for redirecting induced proximity, but evidence is cell-based and non-peer-reviewed.<\/p>\n

The preprint was posted September 13, 2026. The authors report CRBN- and proteasome-dependent NSD2 degradation by 424-ND with suppression of androgen-receptor signaling in prostate-cancer cells. 424-GD selectively degraded GSPT1 and activated ATF4\/ATF3 cellular-stress programs. Biolayer interferometry, molecular dynamics, and metadynamics were used to connect selectivity with ternary-complex cooperativity and conformational ensembles.<\/p>\n

No animal efficacy, pharmacokinetics, tissue distribution, off-target proteomics, chronic toxicity, immunogenicity, formulation, scalable synthesis, or manufacturing data were presented in the discoverable record. Patent position and freedom to operate were not established. The work has not undergone peer review.<\/p>\n

Deep Analysis<\/h4>\n

One interpretation is that local atomic edits can deliberately tune degrader neosubstrate selection by reshaping ternary-complex cooperativity. Orthogonal binding and simulation results plus divergent degradation phenotypes support that model. Against it, closely related compounds can differ in permeability, intracellular concentration, or kinetics, and computational ensembles do not by themselves prove the causal structural mechanism. A second interpretation is that the result is scaffold-specific serendipity framed after optimization. The dual starting point makes redirection plausible, but generality across E3 ligases, targets, and chemotypes has not been shown.<\/p>\n

Company and Product Background<\/h4>\n

NSD2 is a histone methyltransferase implicated in cancer epigenetics and androgen-receptor signaling. GSPT1 is a translation-termination factor frequently recruited as a neosubstrate by CRBN-binding molecular glues; its degradation can trigger integrated-stress responses but also creates systemic toxicity risk. PROTACs physically link a target to an E3 ligase, whereas molecular glues remodel an E3 interface to recruit a neosubstrate without a classical bifunctional linker.<\/p>\n

Signal Extraction<\/h4>\n
    \n
  • The compelling insight is not either lead molecule; it is the possibility that very small scaffold changes can redirect an induced-proximity system between PROTAC-like and molecular-glue behavior.<\/li>\n
  • Upgrades with:<\/strong> solved ternary structures, quantitative proteome-wide selectivity, rescue experiments, matched intracellular exposure, in-vivo target degradation and efficacy, and prospective success on unrelated scaffolds.<\/li>\n
  • Downgrades with:<\/strong> broad neosubstrate loss, poor pharmacokinetics, toxicity from GSPT1 depletion, weak tumor penetration, or simulations that fail structural validation.<\/li>\n
  • Falsified if:<\/strong> prospective atomic edits cannot reproducibly predict direction of degradation as a general design principle.<\/li>\n<\/ul>\n

    InSilens Take<\/h4>\n

    The compelling insight is not either lead molecule; it is the possibility that very small scaffold changes can redirect an induced-proximity system between PROTAC-like and molecular-glue behavior. Translation remains distant because selectivity, exposure, safety, and generalizability have not yet crossed the in-vivo threshold.<\/p>\n

    Signal Assessment<\/h4>\n

    Signal strength:<\/strong> 4\/5 \u2014 a potentially general design rule across two major induced-proximity modalities. Importance:<\/strong> High \u2014 could inform a broad class of degrader design strategies if it generalizes. Confidence:<\/strong> Moderate-high on facts, low-moderate on interpretation \u2014 methods are described in a public preprint but await peer review, and causality, in-vivo translation, and generalizability remain unresolved.<\/p>\n","protected":false},"excerpt":{"rendered":"

    A bioRxiv preprint reports that small \u201cmolecular editing\u201d changes converted LLC0424, a dual NSD2\/GSPT1 degrader, into two selective compounds: fluorine substitution produced the NSD2-directed PROTAC 424-ND, while methylene insertion produced the GSPT1 molecular glue…<\/p>\n","protected":false},"author":1,"featured_media":3170,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,4],"tags":[380,281,275],"class_list":["post-3160","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-categories","category-technology-modalities","tag-molecular-glue","tag-protac","tag-targeted-protein-degradation"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/3160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3160"}],"version-history":[{"count":2,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/3160\/revisions"}],"predecessor-version":[{"id":3184,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/3160\/revisions\/3184"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/3170"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}